AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Abivog GM 2mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Alpic Biotech Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Abivog GM 2mg/500mg/0.2mg Tablet SR

Glycemic control in adults with type 2 diabetes mellitus is achieved with the anti-diabetic combination medication, Abivog GM 2mg/500mg/0.2mg SR tablets. This medication helps regulate blood sugar and should be ingested with food at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continued use, even with controlled blood sugar, is crucial; discontinuation without medical supervision risks hyperglycemia and complications including nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential preventative measures. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections; weight gain may also occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Abivog GM 2mg/500mg/0.2mg Tablet SR

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Abivog GM 2mg/500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Abivog GM 2mg/500mg/0.2mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Abivog GM 2mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.

Common Side effects of Abivog GM 2mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Abivog GM 2mg/500mg/0.2mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Abivog GM 2mg/500mg/0.2mg Tablet SR should be swallowed whole; do not crush, chew, or divide it. Administer this medication on an empty stomach.

How Abivog GM 2mg/500mg/0.2mg Tablet SR works:

Abivog GM extended-release tablets (2mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Abivog GM 2mg/500mg/0.2mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Abivog GM 2mg/500mg/0.2mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Abivog GM tablets (2mg/500mg/0.2mg) are likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Abivog GM 2mg/500mg/0.2mg Tablet SR in individuals with kidney impairment carries a high risk and is best avoided. Patients with severe kidney disease should definitely not take this medication. Medical advice is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Abivog GM 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a reduced dose; however, the medication is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Abivog GM 2mg/500mg/0.2mg Tablet SR :

Should you forget to take a dose of Abivog GM 2mg/500mg/0.2mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Abivog GM 2mg/500mg/0.2mg Tablet SR

LabelValue
Addictive None.
Type of Medication Medication for diabetes

FAQs on Abivog GM 2mg/500mg/0.2mg Tablet SR

Abivog GM 2mg/500mg/0.2mg Extended-Release Tablets contain glimepiride, metformin, and voglibose. This triple-drug formulation manages type 2 diabetes mellitus in adults, enhancing blood glucose control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood sugar. Metformin reduces hepatic glucose production and improves insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, decreases post-meal blood glucose. This combination therapy is unsuitable for type 1 diabetes mellitus.
Patients taking Abivog GM 2mg/500mg/0.2mg Tablet SR may experience common adverse reactions including low blood sugar, nausea, diarrhea, taste changes, gas, abdominal pain, headache, skin rash, and respiratory infections.
Patients with hypersensitivity to Abivog GM 2mg/500mg/0.2mg Tablet SR constituents or inactive ingredients should not take this medication. This medicine is contraindicated for individuals with moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, and metabolic acidosis, including diabetic ketoacidosis.
Combining Abivog GM 2mg/500mg/0.2mg SR tablets and alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and raises the likelihood of lactic acidosis.
Indeed, Abivog GM 2mg/500mg/0.2mg Extended-Release Tablets can induce hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Abivog GM 2mg/500mg/0.2mg...
90
MRP 110
18% off